An opportunity to test your National Patient Safety Alert process in relation to the guidance on GLP-1 prescribing
A National Patient Safety Alert was issued on 18 July relating to GLP-1 receptor agonists (RAs). The alert outlines actions for prescribers:[…]
Read more